Global Assisted Reproductive Technologies Medications Market Research Report 2023

Assisted reproductive technology (ART) is used to treat infertility. It includes fertility treatments that handle both eggs and sperm. A number of different agents are used to achieve controlled ovarian hyperstimulation. These include clomiphene, GnRH analogues, menotropins, urofollitropin, highly purified FSH, and recombinant human FSH (rh-FSH), etc.

The global Assisted Reproductive Technologies Medications market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Assisted Reproductive Technologies Medications is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Assisted Reproductive Technologies Medications is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Assisted Reproductive Technologies Medications in Hospital Pharmacy is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Assisted Reproductive Technologies Medications include Merck, MSD, Ipsen, Ferring, Organon, Solvay, Besins, Zhejiang Xianju and Changchun GeneScience, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Assisted Reproductive Technologies Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Assisted Reproductive Technologies Medications.

The Assisted Reproductive Technologies Medications market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Assisted Reproductive Technologies Medications market comprehensively. Regional market sizes, concerning products by type, by channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Assisted Reproductive Technologies Medications companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by channel, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Assisted Reproductive Technologies Medications Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Down-Regulation Drugs

1.2.3 Ovulation Stimulation Drugs

1.2.4 Ovulation Inducing Drugs

1.2.5 Luteal Support Medications

1.3 Market by Channel

1.3.1 Global Assisted Reproductive Technologies Medications Market Growth by Channel: 2018 VS 2022 VS 2029

1.3.2 Hospital Pharmacy

1.3.3 Specialty & Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Assisted Reproductive Technologies Medications Market Perspective (2018-2029)

2.2 Assisted Reproductive Technologies Medications Growth Trends by Region

2.2.1 Global Assisted Reproductive Technologies Medications Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Assisted Reproductive Technologies Medications Historic Market Size by Region (2018-2023)

2.2.3 Assisted Reproductive Technologies Medications Forecasted Market Size by Region (2024-2029)

2.3 Assisted Reproductive Technologies Medications Market Dynamics

2.3.1 Assisted Reproductive Technologies Medications Industry Trends

2.3.2 Assisted Reproductive Technologies Medications Market Drivers

2.3.3 Assisted Reproductive Technologies Medications Market Challenges

2.3.4 Assisted Reproductive Technologies Medications Market Restraints

3.1 Global Top Assisted Reproductive Technologies Medications Players by Revenue

3.1.1 Global Top Assisted Reproductive Technologies Medications Players by Revenue (2018-2023)

3.1.2 Global Assisted Reproductive Technologies Medications Revenue Market Share by Players (2018-2023)

3.2 Global Assisted Reproductive Technologies Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Assisted Reproductive Technologies Medications Revenue

3.4 Global Assisted Reproductive Technologies Medications Market Concentration Ratio

3.4.1 Global Assisted Reproductive Technologies Medications Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Assisted Reproductive Technologies Medications Revenue in 2022

3.5 Assisted Reproductive Technologies Medications Key Players Head office and Area Served

3.6 Key Players Assisted Reproductive Technologies Medications Product Solution and Service

3.7 Date of Enter into Assisted Reproductive Technologies Medications Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Assisted Reproductive Technologies Medications Historic Market Size by Type (2018-2023)

4.2 Global Assisted Reproductive Technologies Medications Forecasted Market Size by Type (2024-2029)

5.1 Global Assisted Reproductive Technologies Medications Historic Market Size by Channel (2018-2023)

5.2 Global Assisted Reproductive Technologies Medications Forecasted Market Size by Channel (2024-2029)

6.1 North America Assisted Reproductive Technologies Medications Market Size (2018-2029)

6.2 North America Assisted Reproductive Technologies Medications Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Assisted Reproductive Technologies Medications Market Size by Country (2018-2023)

6.4 North America Assisted Reproductive Technologies Medications Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Assisted Reproductive Technologies Medications Market Size (2018-2029)

7.2 Europe Assisted Reproductive Technologies Medications Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Assisted Reproductive Technologies Medications Market Size by Country (2018-2023)

7.4 Europe Assisted Reproductive Technologies Medications Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Assisted Reproductive Technologies Medications Market Size (2018-2029)

8.2 Asia-Pacific Assisted Reproductive Technologies Medications Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Assisted Reproductive Technologies Medications Market Size by Region (2018-2023)

8.4 Asia-Pacific Assisted Reproductive Technologies Medications Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Assisted Reproductive Technologies Medications Market Size (2018-2029)

9.2 Latin America Assisted Reproductive Technologies Medications Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Assisted Reproductive Technologies Medications Market Size by Country (2018-2023)

9.4 Latin America Assisted Reproductive Technologies Medications Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Assisted Reproductive Technologies Medications Market Size (2018-2029)

10.2 Middle East & Africa Assisted Reproductive Technologies Medications Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country (2018-2023)

10.4 Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Merck

11.1.1 Merck Company Detail

11.1.2 Merck Business Overview

11.1.3 Merck Assisted Reproductive Technologies Medications Introduction

11.1.4 Merck Revenue in Assisted Reproductive Technologies Medications Business (2018-2023)

11.1.5 Merck Recent Development

11.2 MSD

11.2.1 MSD Company Detail

11.2.2 MSD Business Overview

11.2.3 MSD Assisted Reproductive Technologies Medications Introduction

11.2.4 MSD Revenue in Assisted Reproductive Technologies Medications Business (2018-2023)

11.2.5 MSD Recent Development

11.3 Ipsen

11.3.1 Ipsen Company Detail

11.3.2 Ipsen Business Overview

11.3.3 Ipsen Assisted Reproductive Technologies Medications Introduction

11.3.4 Ipsen Revenue in Assisted Reproductive Technologies Medications Business (2018-2023)

11.3.5 Ipsen Recent Development

11.4 Ferring

11.4.1 Ferring Company Detail

11.4.2 Ferring Business Overview

11.4.3 Ferring Assisted Reproductive Technologies Medications Introduction

11.4.4 Ferring Revenue in Assisted Reproductive Technologies Medications Business (2018-2023)

11.4.5 Ferring Recent Development

11.5 Organon

11.5.1 Organon Company Detail

11.5.2 Organon Business Overview

11.5.3 Organon Assisted Reproductive Technologies Medications Introduction

11.5.4 Organon Revenue in Assisted Reproductive Technologies Medications Business (2018-2023)

11.5.5 Organon Recent Development

11.6 Solvay

11.6.1 Solvay Company Detail

11.6.2 Solvay Business Overview

11.6.3 Solvay Assisted Reproductive Technologies Medications Introduction

11.6.4 Solvay Revenue in Assisted Reproductive Technologies Medications Business (2018-2023)

11.6.5 Solvay Recent Development

11.7 Besins

11.7.1 Besins Company Detail

11.7.2 Besins Business Overview

11.7.3 Besins Assisted Reproductive Technologies Medications Introduction

11.7.4 Besins Revenue in Assisted Reproductive Technologies Medications Business (2018-2023)

11.7.5 Besins Recent Development

11.8 Zhejiang Xianju

11.8.1 Zhejiang Xianju Company Detail

11.8.2 Zhejiang Xianju Business Overview

11.8.3 Zhejiang Xianju Assisted Reproductive Technologies Medications Introduction

11.8.4 Zhejiang Xianju Revenue in Assisted Reproductive Technologies Medications Business (2018-2023)

11.8.5 Zhejiang Xianju Recent Development

11.9 Changchun GeneScience

11.9.1 Changchun GeneScience Company Detail

11.9.2 Changchun GeneScience Business Overview

11.9.3 Changchun GeneScience Assisted Reproductive Technologies Medications Introduction

11.9.4 Changchun GeneScience Revenue in Assisted Reproductive Technologies Medications Business (2018-2023)

11.9.5 Changchun GeneScience Recent Development

11.10 Hybio Pharmaceutical

11.10.1 Hybio Pharmaceutical Company Detail

11.10.2 Hybio Pharmaceutical Business Overview

11.10.3 Hybio Pharmaceutical Assisted Reproductive Technologies Medications Introduction

11.10.4 Hybio Pharmaceutical Revenue in Assisted Reproductive Technologies Medications Business (2018-2023)

11.10.5 Hybio Pharmaceutical Recent Development

11.11 Livzon Pharmaceutical

11.11.1 Livzon Pharmaceutical Company Detail

11.11.2 Livzon Pharmaceutical Business Overview

11.11.3 Livzon Pharmaceutical Assisted Reproductive Technologies Medications Introduction

11.11.4 Livzon Pharmaceutical Revenue in Assisted Reproductive Technologies Medications Business (2018-2023)

11.11.5 Livzon Pharmaceutical Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Assisted Reproductive Technologies Medications Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Down-Regulation Drugs

    Table 3. Key Players of Ovulation Stimulation Drugs

    Table 4. Key Players of Ovulation Inducing Drugs

    Table 5. Key Players of Luteal Support Medications

    Table 6. Global Assisted Reproductive Technologies Medications Market Size Growth by Channel (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Assisted Reproductive Technologies Medications Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Assisted Reproductive Technologies Medications Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Assisted Reproductive Technologies Medications Market Share by Region (2018-2023)

    Table 10. Global Assisted Reproductive Technologies Medications Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Assisted Reproductive Technologies Medications Market Share by Region (2024-2029)

    Table 12. Assisted Reproductive Technologies Medications Market Trends

    Table 13. Assisted Reproductive Technologies Medications Market Drivers

    Table 14. Assisted Reproductive Technologies Medications Market Challenges

    Table 15. Assisted Reproductive Technologies Medications Market Restraints

    Table 16. Global Assisted Reproductive Technologies Medications Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Assisted Reproductive Technologies Medications Market Share by Players (2018-2023)

    Table 18. Global Top Assisted Reproductive Technologies Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Assisted Reproductive Technologies Medications as of 2022)

    Table 19. Ranking of Global Top Assisted Reproductive Technologies Medications Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Assisted Reproductive Technologies Medications Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Assisted Reproductive Technologies Medications Product Solution and Service

    Table 23. Date of Enter into Assisted Reproductive Technologies Medications Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Assisted Reproductive Technologies Medications Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Assisted Reproductive Technologies Medications Revenue Market Share by Type (2018-2023)

    Table 27. Global Assisted Reproductive Technologies Medications Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Assisted Reproductive Technologies Medications Revenue Market Share by Type (2024-2029)

    Table 29. Global Assisted Reproductive Technologies Medications Market Size by Channel (2018-2023) & (US$ Million)

    Table 30. Global Assisted Reproductive Technologies Medications Revenue Market Share by Channel (2018-2023)

    Table 31. Global Assisted Reproductive Technologies Medications Forecasted Market Size by Channel (2024-2029) & (US$ Million)

    Table 32. Global Assisted Reproductive Technologies Medications Revenue Market Share by Channel (2024-2029)

    Table 33. North America Assisted Reproductive Technologies Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Assisted Reproductive Technologies Medications Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Assisted Reproductive Technologies Medications Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Assisted Reproductive Technologies Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Assisted Reproductive Technologies Medications Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Assisted Reproductive Technologies Medications Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Assisted Reproductive Technologies Medications Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Assisted Reproductive Technologies Medications Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Assisted Reproductive Technologies Medications Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Assisted Reproductive Technologies Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Assisted Reproductive Technologies Medications Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Assisted Reproductive Technologies Medications Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Assisted Reproductive Technologies Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Merck Company Detail

    Table 49. Merck Business Overview

    Table 50. Merck Assisted Reproductive Technologies Medications Product

    Table 51. Merck Revenue in Assisted Reproductive Technologies Medications Business (2018-2023) & (US$ Million)

    Table 52. Merck Recent Development

    Table 53. MSD Company Detail

    Table 54. MSD Business Overview

    Table 55. MSD Assisted Reproductive Technologies Medications Product

    Table 56. MSD Revenue in Assisted Reproductive Technologies Medications Business (2018-2023) & (US$ Million)

    Table 57. MSD Recent Development

    Table 58. Ipsen Company Detail

    Table 59. Ipsen Business Overview

    Table 60. Ipsen Assisted Reproductive Technologies Medications Product

    Table 61. Ipsen Revenue in Assisted Reproductive Technologies Medications Business (2018-2023) & (US$ Million)

    Table 62. Ipsen Recent Development

    Table 63. Ferring Company Detail

    Table 64. Ferring Business Overview

    Table 65. Ferring Assisted Reproductive Technologies Medications Product

    Table 66. Ferring Revenue in Assisted Reproductive Technologies Medications Business (2018-2023) & (US$ Million)

    Table 67. Ferring Recent Development

    Table 68. Organon Company Detail

    Table 69. Organon Business Overview

    Table 70. Organon Assisted Reproductive Technologies Medications Product

    Table 71. Organon Revenue in Assisted Reproductive Technologies Medications Business (2018-2023) & (US$ Million)

    Table 72. Organon Recent Development

    Table 73. Solvay Company Detail

    Table 74. Solvay Business Overview

    Table 75. Solvay Assisted Reproductive Technologies Medications Product

    Table 76. Solvay Revenue in Assisted Reproductive Technologies Medications Business (2018-2023) & (US$ Million)

    Table 77. Solvay Recent Development

    Table 78. Besins Company Detail

    Table 79. Besins Business Overview

    Table 80. Besins Assisted Reproductive Technologies Medications Product

    Table 81. Besins Revenue in Assisted Reproductive Technologies Medications Business (2018-2023) & (US$ Million)

    Table 82. Besins Recent Development

    Table 83. Zhejiang Xianju Company Detail

    Table 84. Zhejiang Xianju Business Overview

    Table 85. Zhejiang Xianju Assisted Reproductive Technologies Medications Product

    Table 86. Zhejiang Xianju Revenue in Assisted Reproductive Technologies Medications Business (2018-2023) & (US$ Million)

    Table 87. Zhejiang Xianju Recent Development

    Table 88. Changchun GeneScience Company Detail

    Table 89. Changchun GeneScience Business Overview

    Table 90. Changchun GeneScience Assisted Reproductive Technologies Medications Product

    Table 91. Changchun GeneScience Revenue in Assisted Reproductive Technologies Medications Business (2018-2023) & (US$ Million)

    Table 92. Changchun GeneScience Recent Development

    Table 93. Hybio Pharmaceutical Company Detail

    Table 94. Hybio Pharmaceutical Business Overview

    Table 95. Hybio Pharmaceutical Assisted Reproductive Technologies Medications Product

    Table 96. Hybio Pharmaceutical Revenue in Assisted Reproductive Technologies Medications Business (2018-2023) & (US$ Million)

    Table 97. Hybio Pharmaceutical Recent Development

    Table 98. Livzon Pharmaceutical Company Detail

    Table 99. Livzon Pharmaceutical Business Overview

    Table 100. Livzon Pharmaceutical Assisted Reproductive Technologies Medications Product

    Table 101. Livzon Pharmaceutical Revenue in Assisted Reproductive Technologies Medications Business (2018-2023) & (US$ Million)

    Table 102. Livzon Pharmaceutical Recent Development

    Table 103. Research Programs/Design for This Report

    Table 104. Key Data Information from Secondary Sources

    Table 105. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Assisted Reproductive Technologies Medications Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Assisted Reproductive Technologies Medications Market Share by Type: 2022 VS 2029

    Figure 3. Down-Regulation Drugs Features

    Figure 4. Ovulation Stimulation Drugs Features

    Figure 5. Ovulation Inducing Drugs Features

    Figure 6. Luteal Support Medications Features

    Figure 7. Global Assisted Reproductive Technologies Medications Market Size Comparison by Channel (2023-2029) & (US$ Million)

    Figure 8. Global Assisted Reproductive Technologies Medications Market Share by Channel: 2022 VS 2029

    Figure 9. Hospital Pharmacy Case Studies

    Figure 10. Specialty & Retail Pharmacy Case Studies

    Figure 11. Online Pharmacy Case Studies

    Figure 12. Assisted Reproductive Technologies Medications Report Years Considered

    Figure 13. Global Assisted Reproductive Technologies Medications Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Assisted Reproductive Technologies Medications Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Assisted Reproductive Technologies Medications Market Share by Region: 2022 VS 2029

    Figure 16. Global Assisted Reproductive Technologies Medications Market Share by Players in 2022

    Figure 17. Global Top Assisted Reproductive Technologies Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Assisted Reproductive Technologies Medications as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Assisted Reproductive Technologies Medications Revenue in 2022

    Figure 19. North America Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Assisted Reproductive Technologies Medications Market Share by Country (2018-2029)

    Figure 21. United States Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Assisted Reproductive Technologies Medications Market Share by Country (2018-2029)

    Figure 25. Germany Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Assisted Reproductive Technologies Medications Market Share by Region (2018-2029)

    Figure 33. China Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Assisted Reproductive Technologies Medications Market Share by Country (2018-2029)

    Figure 41. Mexico Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Assisted Reproductive Technologies Medications Market Share by Country (2018-2029)

    Figure 45. Turkey Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Assisted Reproductive Technologies Medications Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Merck Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2018-2023)

    Figure 48. MSD Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2018-2023)

    Figure 49. Ipsen Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2018-2023)

    Figure 50. Ferring Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2018-2023)

    Figure 51. Organon Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2018-2023)

    Figure 52. Solvay Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2018-2023)

    Figure 53. Besins Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2018-2023)

    Figure 54. Zhejiang Xianju Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2018-2023)

    Figure 55. Changchun GeneScience Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2018-2023)

    Figure 56. Hybio Pharmaceutical Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2018-2023)

    Figure 57. Livzon Pharmaceutical Revenue Growth Rate in Assisted Reproductive Technologies Medications Business (2018-2023)

    Figure 58. Bottom-up and Top-down Approaches for This Report

    Figure 59. Data Triangulation

    Figure 60. Key Executives Interviewed